Lucentis effective for proliferative diabetic retinopathy

Submitted by Elman Retina Group on November 13, 2015

Elman Retina Group key center in NIH-funded clinical trial – marks first major advance in therapy in 40 years A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy. The trial, conducted by the Diabetic Retinopathy Clinical Research Network ( compared Lucentis with a type of…Read More→

The Benefits of ForeseeHome for Macular Degeneration

Submitted by Elman Retina Group on November 3, 2015

At the Elman Retina Group, we believe that the best patient outcomes happen when best-practice interventions are provided alongside prevention. It’s why we stand behind the ForeseeHome AMD Monitoring Program as an advanced and powerful tool to help maximize patients’ quality of living. What is Age-Related Macular Degeneration (AMD)? At least 10 million people in the United…Read More→

What is Retinal Detachment?

Submitted by Elman Retina Group on October 2, 2015

Here at Elman retina Group, we diagnose and treat retinal detachment in order to help you preserve your vision. Retinal Detachment The retina is located on the inside back of the eye and is connected to the optic nerve. It is responsible for transmitting light or visual images to the brain through the optic nerve…Read More→